Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy by Kirk Edwin P, Sunde Margaret, Costa Mauro W, Rankin Scott A, Wolstein Orit, Castro M Leticia, Butler Tanya L, Hyun Changbaig, Guo Guanglan, Otway Robyn, Mackay Joel P, Waddell Leigh B, Cole Andrew D, Hayward Christopher, Keogh Anne, Macdonald Peter, Griffiths Lyn, Fatkin Diane, Sholler Gary F, Zorn Aaron M, Feneley Michael P, Winlaw David S, Harvey Richard P in American journal of human genetics (2007).

[PMID: 17668378] PubMed


The T-box family transcription factor gene TBX20 acts in a conserved regulatory network, guiding heart formation and patterning in diverse species. Mouse Tbx20 is expressed in cardiac progenitor cells, differentiating cardiomyocytes, and developing valvular tissue, and its deletion or RNA interference-mediated knockdown is catastrophic for heart development. TBX20 interacts physically, functionally, and genetically with other cardiac transcription factors, including NKX2-5, GATA4, and TBX5, mutations of which cause congenital heart disease (CHD). Here, we report nonsense (Q195X) and missense (I152M) germline mutations within the T-box DNA-binding domain of human TBX20 that were associated with a family history of CHD and a complex spectrum of developmental anomalies, including defects in septation, chamber growth, and valvulogenesis. Biophysical characterization of wild-type and mutant proteins indicated how the missense mutation disrupts the structure and function of the TBX20 T-box. Dilated cardiomyopathy was a feature of the TBX20 mutant phenotype in humans and mice, suggesting that mutations in developmental transcription factors can provide a sensitized template for adult-onset heart disease. Our findings are the first to link TBX20 mutations to human pathology. They provide insights into how mutation of different genes in an interactive regulatory circuit lead to diverse clinical phenotypes, with implications for diagnosis, genetic screening, and patient follow-up.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.